Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
2047.0000
-76.30
(
-3.59
%)
NSE
Mar 04, 2026
13:30 PM
58.86% Gain from 52W Low
Volume:
245.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
26 May 2023
2047.00
-3.59%
GLENMARK PHARMACEUTICALS
Hold:
Glenmark Pharmaceuticals Ltd.
by
Geojit BNP Paribas
Target: 638
Recommendation
Target
Geojit BNP Paribas
Number of FII/FPI investors increased from 401 to 422 in Dec 2025 qtr.
More from Glenmark Pharmaceuticals Ltd.
Recommended
Market trades lower, Metal stocks fall as aluminium prices surge on supply fears
Trendlyne Marketwatch |
04 Mar 2026, 01:31PM
Bad timing: New listings sink on debut amid market turmoil
|
02 Mar 2026, 05:29PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020